Siemens U.S. healthcare unit appoints Reitermann as CEO

Michael Reitermann has been appointed the new CEO of Siemens Healthcare's U.S. organization.

In his new position, Reitermann will lead the marketing, sales and service functions for Siemens Healthcare in the U.S., including the medical imaging, therapy and health IT businesses. He will be based at the U.S. headquarters in Malvern, Pa.

Reitermann succeeds Heinrich Kolem, MD, who will assume the role of global head of Siemens Healthcare's angiography, fluoroscopy and x-ray business unit, based in Forchheim, Germany.

Reitermann has worked as a senior project manager at the corporate strategies division as well as a partner in Siemens Management Consulting. Reitermann also served as vice president for sales, marketing and innovation ofunit, and president of the former nuclear medicine division since July 2002, Reitermann was responsible for the establishment and implementation of MI's global business objectives.

Since 2006, Kolem was the CEO of the Siemens Healthcare organization in the United States overseeing launches of imaging systems such as the Somatom Definition Flash, Magnetom Essenza, Biograph mCT and the Acuson S2000. Kolem started his Siemens career in the field of MRI in 1989.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup